Skip to main content

Table 3 Comparison of serum levels of inflammatory factors before and after treatment between the two groups (\(\stackrel{-}{x}\) ± SD)

From: Effect and mechanism of HMG-CoA reductase inhibitor on the improvement of elderly essential hypertension-induced vascular endothelial function impairment based on the JAK/STAT pathway

Indicator

 

Control group (n = 43)

Observation group (n = 43)

IL-6 (ng/L)

Before treatment

15.15 ± 3.27

15.40 ± 3.65

After treatment

9.38 ± 2.03*

7.54 ± 1.12*#

TNF-α (ng/L)

Before treatment

19.35 ± 3.69

19.57 ± 3.51

After treatment

15.41 ± 2.15*

13.22 ± 2.08*#

hs-CRP (mg/L)

Before treatment

8.87 ± 1.86

8.92 ± 2.18

After treatment

6.28 ± 1.50*

3.08 ± 1.02*#

  1. Note: * p < 0.05 vs. Before treatment; # p < 0.05 vs. Control group